Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pneumonia × Clinical Protocols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 4 Recurrence 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pneumonia 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms, Plasma Cell 1 Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Locally Advanced Breast Cancer 1 Hepatitis 1 Fibrosis 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Methylprednisolone 2 Bronchoscopy 2 Bronchoalveolar Lavage 2 ziprasidone 1 pirfenidone 1 ceftolozane, tazobactam drug combination 1 Zolpidem 1 XAV-19 1 X-Rays 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Ultrasonography 1 Tranexamic Acid 1 Tobramycin 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Surveys and Questionnaires 1 Standard of Care 1 Spironolactone 1 Sodium Bicarbonate 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Ribavirin 1 Prednisone 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡